Based on the provided content, here's a breakdown of the vulnerability information related to CVE-2020-14525:

**Vulnerability:** Improper Neutralization of Script in Attributes in a Web Page (CWE-83)

*   **Root Cause:** The software fails to properly neutralize user-controllable input before including it in a webpage served to other users. This means that if a user provides malicious input, it could be executed within the context of another user's session.

*   **Weakness:** Improper input sanitization leads to the possibility of injecting malicious scripts into web pages served by the vulnerable application.

*   **Impact:** Successful exploitation could potentially allow an attacker to inject malicious scripts that would execute in the browser of other users interacting with the application. While the specific actions an attacker could perform are not detailed, this could lead to information disclosure, session hijacking, or other malicious activities, potentially leading to sensitive information exposure or unauthorized actions on the system. The information section indicates that it can provide identifying information for subsequent attacks.

*   **Attack Vector:** The attack vector is Adjacent Network (AV:A). This means the attacker needs to be on the same network segment as the affected system. It is not clear if this includes wireless networks or if it is limited to wired network access.

*   **Required Attacker Capabilities/Position:** The attacker needs to have low level access (PR:L) to the vulnerable system to inject malicious data. No user interaction is needed (UI:N) for this to take effect on other users.

**Additional Notes:**

*   The provided CVSS v3 vector string for this vulnerability is (AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N).
*   The affected product is Philips Clinical Collaboration Platform Versions 12.2.1 and prior (previously registered as Vue PACS).
*   Philips released a patch (12.2.1.5) to remediate this issue.